Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
| CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
tsA201 |
Human embryonic kidney cell line | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | C. Bavassano et al., Biochim. et Biophysica Acta, 2013, 1833: 3166–3175, doi.org/10.1016/j.bbamcr.2013.09.001 | Link | ||
TPC1 |
Human thyroid gland papillary carcinoma cell line | Human | other | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | V. Vella et al., Endocrine-Related Cancer, 2019, 26: 197–214, doi.org/10.1530/ERC-18-0310 | |||
SW1736 |
Human thyroid gland undifferentiated (anaplastic) carcinoma cell line | Human | other | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | V. Vella et al., Endocrine-Related Cancer, 2019, 26: 197–214, doi.org/10.1530/ERC-18-0310 | |||
SK-N-BE(2) |
Human neuroblastoma cell line | ATCC CRL-2271 | Human | brain | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | A. Groß et al., Cancer Res., 2018, DOI: 10.1158/0008-5472.CAN-17-1860 | ||
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | S. Sperduti et al., Int. J. Mol. Sci., 2019, 20, 5548, doi:10.3390/ijms20225548 | Link | |
Phoenix |
Retrovirus producer cell line (derivative of 293T) | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | H.F. Alkan et al., bioRxiv preprint, 2020, doi.org/10.1101/2020.05.28.114629 | Link | ||
Phoenix |
Retrovirus producer cell line (derivative of 293T) | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | X. Wang et al., Cell Death & Differentiation, 2021, 28: 3235–3250, doi.org/10.1038/s41418-021-00811-1 | Link | ||
Panc-1 |
Human exocrine pancreas carcinoma cells | ATCC CRL-1469 | Human | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | X. Wu et al., PNAS, Nov 2016, 113: E6965 - E6973 | ||
NCI H1299 |
Human lung carcinoma cell line | ATCC CRL-5803 | Human | respiratory system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | D. Lo et al., Oncogene, 2015, 34:1688-1697; doi:10.1038/onc.2014.103 | ||
MDA-MB-436 |
Human breast cancer cell line | Human | breast | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | L. J. Barlow, Dissertation, 2020, University Graduate School | Link | ||
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | B. von Neubeck et al., Int. J. of Cancer, 2018, 143: 2065–2075, DOI: 10.1002/ijc.31607 | ||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | A. M. Scherbakov et al., Exp. Cell Res., 2013, 319: 3150 – 3159, doi.org/10.1016/j.yexcr.2013.08.019 | ||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | A. M. Scherbakov et al., Chem. Biodiversity, 2019, 16: e1900332, DOI: 10.1002/cbdv.201900332 | Link | |
M3K |
Drug-resistant breast cancer cell line (derivative of MCF7) | Human | breast | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | L. J. Barlow, Dissertation, 2020, University Graduate School | Link | ||
LNCaP |
Human prostate carcinoma cell line | ATCC CRL-1740 | Human | genital tract | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | J. Elvenes et al., PLoS ONE, 2011, 6(9): e24659, doi:10.1371/journal.pone.0024659 | Link | |
LN-229 |
Human brain glioblastoma cell line | ATCC CRL-2611 | Human | brain | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | G. D. Maurer et al., Int. J. Mol. Sci.,2019, 20, 106, doi:10.3390/ijms20051061 | Link | |
LN-229 |
Human brain glioblastoma cell line | ATCC CRL-2611 | Human | brain | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | D. P. Brucker et al., Int. J. of Oncology, 2016, 49:2399-2410; DOI: 10.3892/ijo.2016.3760 | Link | |
HuH7.5 |
Human hepatocarcinoma cell line | Human | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | N. Hagen, Dissertation, 2013, Universität Hamburg | Link | ||
HuH7 |
Human hepatocarcinoma cell line | Human | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | J. W. Tay et al., J. of Thrombosis and Haemostasis, 2013, 11: 1547–1555, DOI: 10.1111/jth.12331 | Link | ||
hUCB-MSC |
Human umbilical cord blood derived mesenchymal stem cells | Human | other | stem cell | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | E. J. Lee et al., Molecular Therapy: Methods & Clinical Development, 2019, 13, doi.org/10.1016/j.omtm.2019.05.003 | Link | |||
HTh74 |
Human thyroid gland undifferentiated (anaplastic) carcinoma cell line | Human | other | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | V. Vella et al., Endocrine-Related Cancer, 2019, 26: 197–214, doi.org/10.1530/ERC-18-0310 | |||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | A. Kaiser et al., Cell. and Mol. Life Sciences, 2019, doi.org/10.1007/s00018-019-03432-7 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | D. P. Reguera et al., Cells, 2020, 9: 443, doi:10.3390/cells9020443 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | M. Ahn et al., Human Gene Ther. Methods, 2012, 24: 1–10, DOI: 10.1089/hgtb.2012.198 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | D. Bierer et al., US20180022780A1 |
 |
Fax-Bestellung |
Geben Sie Ihre Bestellung einfach und bequem per Fax auf unter folgender Nummer:
0049 89 32479952
Europa
0049 89 32479952
USA/Kanada
01149 89 32479952
Australien
001149 89 32479952
 |
Email-Bestellung |
Geben Sie Ihre Bestellung einfach und bequem per Email auf unter folgender Adresse: order@biontex.com
 |
Online-Bestellung |
Für die korrekte Darstellung der Preise und Versandkosten ist die Wahl Ihrer Region nötig.